Understanding how satellite microglia affect brain function after traumatic brain injury.
Satellite Microglia: Role in Maladaptive Network Remodeling after TBI
This study is looking at how a special type of brain cell called satellite microglia behaves after a traumatic brain injury, to see how they might affect thinking and behavior, with the hope of finding new ways to help people recover better after such injuries.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10994630 on NIH RePORTER |
What this research studies
This research investigates the role of satellite microglia, a specific type of immune cell in the brain, in the aftermath of traumatic brain injury (TBI). The study aims to understand how these cells influence neuronal activity and cognitive functions, particularly focusing on their ability to regulate excitability in neurons. By using specialized mouse models, researchers will explore the changes in satellite microglia and their receptors over time following TBI, which may provide insights into the mechanisms behind cognitive deficits and behavioral dysfunction. The findings could lead to new therapeutic strategies for improving recovery after brain injuries.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced a traumatic brain injury and are facing cognitive or behavioral challenges.
Not a fit: Patients with neurological conditions unrelated to traumatic brain injury may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance recovery and cognitive function in patients who have suffered traumatic brain injuries.
How similar studies have performed: Previous research has shown that targeting immune responses in the brain can lead to improvements in recovery from neurological injuries, suggesting that this approach may yield promising results.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Nolan, Amber L — University of Washington
- Study coordinator: Nolan, Amber L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.